Feasibility and willingness-to-pay for integrated community-based tuberculosis testing

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Goswami, Neela D ^a   Hecker, Emily ^a   Holland, David P ^a   Naggie, Susanna ^a   Cox, Gary M ^a   Mosher, Ann ^a   Turner, Debbie ^b   Torres, Yvonne ^b   Vickery, Carter ^b   Ahearn, Marshall A ^a   Blain, Michela L M ^a   Rasmussen, Petra ^a   Stout, Jason E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Wake County Human Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DRUG ABUSE; FEASIBILITY STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HIV TEST; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON GAMMA RELEASE ASSAY; MALE; MASS SCREENING; MULTIPLE CHOICE TEST; OPEN ENDED QUESTIONNAIRE; RISK FACTOR; SYPHILIS; TUBERCULIN TEST; TUBERCULOSIS; WILLINGNESS TO PAY; DIAGNOSTIC PROCEDURES; ECONOMICS; METHODOLOGY; MIDDLE AGED; PATIENT ATTITUDE; QUESTIONNAIRE; STATISTICS;

ADULT; CLINICAL LABORATORY TECHNIQUES; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SYPHILIS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 80055102054     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-305     Document Type: Article

References (15)

1. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000, 161(4 Pt 2):S221-247.
2. Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy 2007, 18(4):306-312. 10.1016/j.drugpo.2007.03.001, 2696234, 17689379.
3. Bock NN, Metzger BS, Tapia JR, Blumberg HM. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med 1999, 159(1):295-300.
4. Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health 1998, 88(5):792-796. 10.2105/AJPH.88.5.792, 1508952, 9585747.
5. Riley ED, Vlahov D, Huettner S, Beilenson P, Bonds M, Chaisson RE. Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program. J Urban Health 2002, 79(1):113-127. 10.1093/jurban/79.1.113, 11937620.
6. Rendleman NJ. Mandated tuberculosis screening in a community of homeless people. Am J Prev Med 1999, 17(2):108-113. 10.1016/S0749-3797(99)00052-5, 10490052.
7. Asch S, Leake B, Anderson R, Gelberg L. Why do symptomatic patients delay obtaining care for tuberculosis?. Am J Respir Crit Care Med 1998, 157(4 Pt 1):1244-1248.
8. Schwarcz S, Richards TA, Frank H, Wenzel C, Chin Hsu L, Chin CS, Murphy J, Dilley J. Identifying barriers to HIV testing: personal and contextual factors associated with late HIV testing. AIDS Care 2011, 1-9.
9. Wolfe H, Marmor M, Maslansky R, Nichols S, Simberkoff M, Des Jarlais D, Moss A. Tuberculosis knowledge among New York City injection drug users. Am J Public Health 1995, 85(7):985-988. 10.2105/AJPH.85.7.985, 1615548, 7604926.
10. West EL, Gadkowski LB, Ostbye T, Piedrahita C, Stout JE. Tuberculosis knowledge, attitudes, and beliefs among North Carolinians at increased risk of infection. N C Med J 2008, 69(1):14-20.
11. Peterson Tulsky J, Castle White M, Young JA, Meakin R, Moss AR. Street talk: knowledge and attitudes about tuberculosis and tuberculosis control among homeless adults. Int J Tuberc Lung Dis 1999, 3(6):528-533.
12. Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 2006, 6:47. 10.1186/1471-2334-6-47, 1434750, 16539718.
13. Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, Moss AR. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med 2000, 160(5):697-702. 10.1001/archinte.160.5.697, 10724056.
14. Malotte CK, Hollingshead JR, Larro M. Incentives vs outreach workers for latent tuberculosis treatment in drug users. Am J Prev Med 2001, 20(2):103-107. 10.1016/S0749-3797(00)00283-X, 11165450.
15. Farmer P, Robin S, Ramilus SL, Kim JY. Tuberculosis, poverty, and "compliance": lessons from rural Haiti. Semin Respir Infect 1991, 6(4):254-260.